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Enantioselective Diels-Alder reactions of 1,2-10 
dihydropyridines with acroleins using a novel chiral 
oxazolidine organocatalyst afforded chiral isoquinuclidines 
that is efficient synthetic intermediate of oseltamivir, with 
fairly good chemical yield and excellent enantioselectivity 
(90%, up to >99% ee).  15 
 
The 2-azabicyclo[2.2.2]octanes (isoquinuclidines) are found 
widely in natural products such as iboga-type indole alkaloids, 
which have varied and interesting biological properties.1  
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In particular, as shown in Scheme 1, there are pharmacologically 
important vinca alkaloids such as vinblastine and vincristion, 35 
which possesses isoquinuclidines, with the aspidosperma 
portion.2 It has recently been indicated that ibogaine reduces 
cravings for alcohol and other drugs by means of its ability to 
boost the levels of a growth factor known as glial cell line-
derived neurotrophic factor (GDNF).3 In addition, most recently 40 
it was also showed that the isoquinuclidines can be used as the 
synthetic intermediate for the synthesis of oseltamivir phosphate 
(Tamiflu) which is an important anti-influenza drug.4 Tamiflu is a 
potent inhibitory of neuraminidase, and is used worldwide as a 
drug for type A or B influenza. Furthermore, isoquinuclidines are 45 
also valuable intermediates in the synthesis of other alkaloids5 
and in medicinal chemistry.6 It is therefore meaningful to 
establish an effective asymmetric synthetic methodology for 
chiral isoquinuclidines. A well-established route to the chiral ring 
system is through the asymmetric Diels-Alder (DA) reaction of 50 
1,2-dihydropyridines with dienophiles. However, only a little 
example of employing organometal catalyst or organocatalyst has 
been reported by our group and others.7 Despite the obvious 
advantages of the catalytic enantioselective version using an 
organocatalyst, to the best of our knowledge, only one example 55 
employing MacMillan catalyst has been  reported for the 
organocatalytic asymmetric version of this reaction that was used 
as the key reaction for the efficient practical total synthesis of 
Tamiflu by Fukuyama and co-workers.4 Nevertheless, this 
reaction afforded low chemical yield (26%), but excellent 60 
enantioselectivity (99% ee).  
   In the present study, we planned to develop a novel 
organocatalyst that afford chiral isoquinuclidines at a practical 
level with regard to both chemical yield and enantioselectivity.                             
   In designing the planned catalyst, we paid attention to our 65 
previously developed      phosphinooxazolidine (POZ) ligand A 
(Scheme 2).7 The Pd-POZ organometalic catalyst  shows an 
excellent catalytic property in the DA reaction with 1,2-
dihydropyridines as a diene.7b,c In the reaction, the substituted 
oxazolidine structure of the catalyst works  effectively to give 70 
high enantioselectivity. Given the above, we designed a series of 
oxazolidines, 2,4-substituted 5,5-diphenyloxazolidines, as a novel 
organocatalyst for the DA reaction of 1,2-dihydropyridines. 
Oxazolidine catalyst is easily prepared by the reaction of an 
amino alcohol with a carbonyl compound. The resulting 75 
compound contains one covalent site, and the stability of the 
oxazolidine ring system can be maintained by the diphenyl 
groups at the 5-position.  
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   We report herein that 2-phenyl-4-tert-butyl-5,5-
diphenyloxazolidine with CF3CO2H exhibits a high degree of 
enantioselectivity (up to >99% ee) and good chemical yield (up to 
90%) in the DA reaction of 1,2-dihydropyridines with acroleins. 
Although a high chemical yield is not obtained in this reaction 5 
using the MacMillan catalyst, this is the first organocatalyst that 
affords the corresponding chiral isoquinuclidines at a practical 
level with regard to both high chemical yield and 
enantioselectivity. 
   The catalysts, respectively, were prepared by the condensation 10 
of the corresponding β-amino alcohol with an aldehyde or a 
ketone, followed by treatment with an organic acid (Scheme 3). 
Thus, the reactions of β-amino alcohols 4a-d with benzaldehyde, 
respectively, afforded the precursor oxazolidine 5 in good 
chemical yields, but the 1H-NMR analysis of the obtained 15 
crystallized products showed a tautomeric mixture of 
oxazolidines 5a-d and imines 5a’-d’. However, the treatments of 
5 with XCO2H (X= CF3, CHF2, CCl3, CBr3) afforded the desired 
chiral oxazolidine salts 6a-g. Thus, the reactions of the 
compounds 5a,b with XCO2H (X= CF3, CCl3, CBr3, CHF2), 20 
respectively, gave the desired catalysts 6a,b,e-g as a single 
structure in quantitative yields. However, the reactions of the 
compounds 5c,d with CF3COOH afforded compound 6c,d as a 
single structure with decomposed product. Furthermore, catalysts 
8a and 8b8 were also obtained from the condensations of 4a,b 25 
with acetone in the presence of MS 4A followed by the treatment 
with CF3CO2H, respectively. In the four compounds 6a-g, the 
assigned stereochemistry at the 2-position of the oxazolidine ring 
was determined by NOE difference spectra. NOE enhancement 
was observed between the hydrogen at the 2-position and the 30 
hydrogen at the 4-position when the 2- and 4-positions were 
irradiated, respectively.6 
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   We first examined the DA reaction of common 1-
phenoxycarbonyl-1,2-dihydropyridine 9 with acrolein 10. The 50 
reaction was carried out at 0 °C in CH3CN-H2O in the presence of 
10mol% of catalysts 6a,b,e-g to give the DA adduct 11, and its 
chemical and optical yields were determined by converting to the 
alcohol 12. The results are summarized in Table 1. The reaction 
catalyzed by 5-tert-butyl-6a with CF3CO2H gave the endo-DA 55 
adduct 11a† in good chemical yield (71%) and excellent 
enantioselectivity (>99% ee) (entry 1). The use of 5-isopropyl-6b 
with CF3CO2H brought about a slight decrease in 
enantioselectivity (97% ee), but the DA adduct was obtained in 
77% (entry 2). In contrast, 2-dimethylated catalysts 8a,b with 60 
tert-butyl or iso-propyl groups at the 5-position afforded both the 
endo and exo DA adducts as a mixture in only low chemical 
yields and enantioselectivity (entries 3, 4). These above results 
indicate that the stereochemistry of the substituent group at the 2-
position of the oxazolidine ring is important for obtaining an 65 
satisfactory enantioselectivity. Catalysts 6e-g with other organic 
acids (XCO2H: X = Cl3C, Br3C, F2CH) also did not give 
satisfactory results for either chemical yield or enantioselectivity 
(entries 5-7). Based on the above, 2-monosubstituted 6a,b might 
be better than the corresponding 2-disubstituted 8a,b in the 70 
reaction. Thus, the substituents at 2- and 4-positions having cis-
configurationon the oxazolidine ring might act to control the 
equilibrium between iminium conformers blocking one iminium 
face from attacking of diene to afford high enantioselectivity. 
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   The activity of most effective catalyst 6a was then evaluated in 90 
the reaction consisting of 10 mol% catalyst with 1-
benzyloxycarbonyl or 1-tert-butoxycarbonyl-1,2-
dihydropyridines (13 and 14) and acrolein 10. The chemical and 
optical yields of the DA adducts 15, 16† were determined by 
converting to the alcohols 17, 18. The results are shown in Table 95 
2. The use of 1-benzyloxycarbonyl-diene 13 further increased 
efficacy of catalyst 6a (entry 1). In this reaction, fairly good 
chemical yield (90%) was observed together with excellent 
enantioselectivity (>99% ee). Furthermore, the effect of reducing 
N
CO2Ph
O
N
CHO
PhO2C
9 11a
N
PhO2C
OH12a
 CH3CN-H2O
(19:1)
0˚C, 24h
Yield  
(%)a
 endo : exob
 (11a : 11b)
endo-11a 
ee (%)cEntry
1
2
3
4
5
6
7
71
70
19
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73
16
53
endo only
''
12 : 1
51 : 1
75 : 1
endo only
''
>99 (S)
  97 (S)
  27 (S)
  85 (S)
  39 (S)
  33 (S)
  42 (S)
aIsolated yields.bThe endo/exo ratio was determined by 1H NMR.cThe ee of 
the endo and exo isomers were determined by chiral HPLC using a Daicel
AD-H column (hexane/2-propanol : 85/15) of 12a,b.
quant.
catalyst 
6a,b,e-g,
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the molar ratio of catalyst 6a were examined. At low catalytic 
loading to 5 mol % of 6a, equally satisfactory results (67%, 97% 
ee, entry 2) were obtained, but 2.5 mol % greatly decreased both 
the chemical yield and enantioselectivity (44%, 85% ee, entry 4). 
Similarly, 6a was also effective in the DA reaction using 1-tert-5 
butoxycarbonyl-diene 14 and the desired DA adduct 16 was 
obtained with almost complete enantioselectivity (>99% ee) with 
a moderate chemical yield (entry 5).  
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   We examined the effectiveness of acrolein derivative 19 using 
superior catalyst 6a (Scheme 3). The reactions of dienes, 9, 13 
with dienophile 19, respectively, were carried out at 0 °C in the 25 
presence of 10 mol% of superior catalyst 6a to give the DA 
adducts 20,† 21,† and those chemical and optical yields were 
determined by converting to the alcohol 22, 23, respectively. The 
desired DA adducts, 20, 21 were obtained in good chemical 
yields and almost complete enantioselectivity (20: 68%, >99% ee, 30 
21: 83%, >99% ee) in the both reactions. This is the first example 
of an enantioselective DA reaction of 1,2-dihydropyridine with 
substituted dienophile using an organocatalyst. 
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   In conclusion, we have succeeded in carrying out a highly 
enantioselective Diels-Alder reaction of 1,2-dihydropyridines that 
provides an efficient methodology for obtaining 45 
pharmacologically important compound such as Tamiflu and its 
derivative, using a novel oxazolidine organocatalyst 6. The 
developed oxazolidine catalyst 6 was easily prepared in two steps 
and showed dramatic reactivity and excellent enantioselectivity 
for the tried all reactions of three kinds of 1,2-dihydropyridines 9, 50 
13, 14 with two kinds of acroleins 10, 19, comparable to the 
results of the report of Fukuyama group.4 Further studies to 
examine the scope and limitations of this organocatalyst for the 
catalytic asymmetric version of the DA reactions of 1,2-
dihydropyridines are now in progress.  55 
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Table 2 Enantioselective DA reaction of 13 or 14 with acrolein using catalysts 6a
N
CHO
RO2C
15a, 16
N
RO2C
OH17a, 18
 CH3CN-H2O
(19:1)
0 °C, 24h quant.
     catalyst 
         6a
N
CHO
BnO2C
15b
N
BnO2C
OH
17b
NaBH4
EtOH
rt, 1 h
10
13: R = Bn
14: R = t-Bu
(10 mol%)
Entry Catalyst
(mol%)
Substrate Product
15,16
yield
(%)a
endo-
15a,16
ee (%)b
1
2
3
4
5
6a (10)
6a (5)
6a (5)
6a (2.5)
6a (10)
13
13
13
13
14
15a
15a
15a
15a,b
16a
90
61
67
44c
51
>99 (S)
97 (S)
97 (S)
85 (S)
>99 (S)
aIsolated yields. bThe ee of the endo and exo isomers were determined  by chiral 
HPLC using a Daicel chiral column of 17a,b, 18.c The endo/exo ratio was 67:33, 
which was determined by 1H NMR.
Time
 (h)
24
24
48
24
24
exo-
15b
ee (%)b
15: R = Bn, 16: R = t-Bu 17: R = Bn, 18: R = t-Bu
73
+
N
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O
O
N
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20: R = Ph,  endo only
         68%, > 99%ee     
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19
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Scheme 4 Enantioselective DA reactions of 9 or 13 with 19 using 
catalyst 6a
22: R = Ph, 23: R = Bn
  9  or 13
